Xenon Pharmaceuticals to Present at the Wells Fargo 2023 Healthcare Conference
Thursday, August 31, 2023 1 min read
Key Takeaway: Xenon Pharmaceuticals Inc. has announced its participation in the Wells Fargo 2023 Healthcare Conference scheduled for September 6-8, 2023. Ian Mortimer, the President and CEO, along with Chief Commercial Officer Chris Von Seggern, will present during a fireside chat. This event aims to showcase Xenon's innovative therapeutic developments for neurological disorders, particularly focusing on epilepsy. A live webcast of the presentation will be available on their website.
Market Sentiment Analysis
POSITIVE FACTORS
Xenon Pharmaceuticals will present at a major healthcare conference.
The presentation will highlight advancements in their neurology-focused pipeline.
Leaders of the company, including the CEO, will be presenting, reflecting confidence.
Full Press Release Details
VANCOUVER, British Columbia, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the Wells Fargo 2023 Healthcare Conference to be held September 6-8, 2023.
Company Fireside Chat Presentation Details:
Date:
Wednesday, September 6, 2023
Time:
2:15 pm Eastern Time
Webcast:
Register here
Presenters:
Ian Mortimer, President and Chief Executive Officer
Chris Von Seggern, Chief Commercial Officer
A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.